Publication date: Sep 08, 2025
Managing bronchiectasis exacerbations is a priority for patients/parents/caregivers of children with bronchiectasis, yet evidence-based strategies among the pediatric population remain limited. Does the use of a personalized, written bronchiectasis action management plan (BAMP), compared to standard care, reduce non-scheduled doctor visits among children/adolescents with chronic suppurative lung disease (CSLD)/bronchiectasis? Our multicenter, double-blind, superiority, randomized controlled trial enrolled children from three Australian respiratory departments between June 2018 and December 2020. Children/adolescents aged
| Concepts | Keywords |
|---|---|
| Australian | action management plan |
| Blind | bronchiectasis |
| June | children |
| Parents | randomized controlled trial |
| Pediatric | respiratory infections |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | bronchiectasis |
| disease | MESH | lung disease |
| disease | MESH | respiratory infections |
Original Article
(Visited 2 times, 1 visits today)